Current psychopharmacological nomenclature remains wedded to earlier period of scientific understanding, failing to reflect contemporary developments and knowledge, does not help clinicians to select the best medication for a given patient, and tending to confuse patients as they are being given a drug with a different name compared to their identified diagnosis (e.g. "Antipsychotic" for depression).
William T. Cefalu, Andrew J.M. Boulton, William V. Tamborlane, Robert G. Moses, Derek LeRoith, Eddie L. Greene, Frank B Hu, George L. Bakris, Judith Wylie‐Rosett, Julio Rosenstock, Katie Weinger, Lawrence Blonde, Mary de Groot, Matthew C. Riddle, Robert R. Henry, Sherita Hill Golden, Stephen S. Rich, L. Raymond Reynolds
Discussion(0)
No comments yet. Be the first to comment.